Markers of thrombosis and hemostasis in acute coronary syndromes: relationship to increased heart rate and reduced heart-rate variability.

scientific article published in April 2009

Markers of thrombosis and hemostasis in acute coronary syndromes: relationship to increased heart rate and reduced heart-rate variability. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/CLC.20321
P932PMC publication ID6653381
P698PubMed publication ID19353696
P5875ResearchGate publication ID24264092

P50authorGregory LipQ60393087
Andrew D BlannQ102066226
P2093author name stringAli Hamaad
Robert J MacFadyen
Michael D Sosin
P2860cites workHeart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and ElectrophysiologyQ29547464
Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.Q33183129
Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarctionQ33917874
Decreased heart rate variability and its association with increased mortality after acute myocardial infarctionQ34191387
Incremental shuttle walking is associated with activation of haemostatic and haemorheological markers in patients with coronary artery disease: the Birmingham rehabilitation uptake maximization study (BRUM)Q35584888
Hemodynamic, hemostatic, and endothelial reactions to psychological and physical stress in coronary artery disease patientsQ40413474
Elevated soluble P-selectin levels are associated with an increased risk of early adverse events in patients with presumed myocardial ischemiaQ42042586
Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart diseaseQ44806693
Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart).Q50634803
The influence of anxiety in tests of blood coagulability and fibrinolytic activity.Q51355532
Platelet aggregability in humans: contrasting in vivo and in vitro findings during sympatho-adrenal activation and relationship to serum lipids.Q52056766
Effect of mental stress on the fibrinolytic reactivity to exerciseQ52129535
Comparative behaviour of the components of the factor VIII complex in acute myocardial infarction.Q53868783
Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart StudyQ56212914
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable AnginaQ58230388
Soluble CD40 Ligand in Acute Coronary SyndromesQ58816350
Some Effects of Adrenaline and Anti-Adrenaline Compounds on Platelets in vitro and in vivoQ59058800
Alteration in second phase platelet aggregation associated with an emotionally stressful activityQ67024655
Platelet aggregation in aortic and coronary venous blood in patients with and without coronary disease. 3. Role of tachycardia stress and propranololQ67391117
Conditions affecting the responses of human platelets to epinephrineQ68017744
Time course of recovery of heart period variability after myocardial infarctionQ68071759
Heart rate variability during the acute phase of myocardial infarctionQ68134015
Adrenergic mechanisms in the systemic plasminogen active response to adrenaline in manQ68745617
Heart rate variability as an index of sympathovagal interaction after acute myocardial infarctionQ69461302
Elevated serum D dimer: a degradation product of cross-linked fibrin (XDP) after intravenous streptokinase during acute myocardial infarctionQ69518069
Platelet function in patients admitted with a diagnosis of myocardial infarctionQ69894008
Plasma catecholamines, platelet aggregation and associated thromboxane formation after physical exercise, smoking or norepinephrine infusionQ70238189
Retarding effect of lowered heart rate on coronary atherosclerosisQ70631626
Elevated plasma interleukin-6 levels in patients with acute myocardial infarctionQ72630338
Soluble P-selectin and the success of thrombolysis in acute myocardial infarctionQ74230125
Early temporal expression of soluble cellular adhesion molecules in patients with unstable angina and subendocardial myocardial infarctionQ77361754
Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromesQ78108701
Markers of inflammation in acute coronary syndromes: association with increased heart rate and reductions in heart rate variabilityQ82230801
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectthrombosisQ261327
acute coronary syndromeQ266018
heart rate variabilityQ933954
P304page(s)204-209
P577publication date2009-04-01
P1433published inClinical CardiologyQ4502312
P1476titleMarkers of thrombosis and hemostasis in acute coronary syndromes: relationship to increased heart rate and reduced heart-rate variability
P478volume32

Reverse relations

cites work (P2860)
Q36293723Resilience to orthostasis and haemorrhage: A pilot study of common genetic and conditioning mechanisms
Q84242158Shortened activated partial thromboplastin time, a hemostatic marker for hypercoagulable state during acute coronary event
Q37891258Viral serpin therapeutics from concept to clinic.

Search more.